M. Dorreen

498 total citations
23 papers, 390 citations indexed

About

M. Dorreen is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Dorreen has authored 23 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Dorreen's work include Lymphoma Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (4 papers) and Lung Cancer Treatments and Mutations (4 papers). M. Dorreen is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (4 papers) and Lung Cancer Treatments and Mutations (4 papers). M. Dorreen collaborates with scholars based in United Kingdom and Canada. M. Dorreen's co-authors include Tim Lister, P. F. M. Wrigley, A G Stansfeld, J A Habeshaw, A. E. Jones, M. Fox, Stefan Glück, T. Younis, Pedro López and Colin Germond and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

M. Dorreen

23 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Dorreen United Kingdom 13 178 151 80 80 74 23 390
T. P. Vassilakopoulos Greece 12 271 1.5× 160 1.1× 42 0.5× 81 1.0× 166 2.2× 19 502
Kong‐Chao Chang Taiwan 8 111 0.6× 155 1.0× 29 0.4× 63 0.8× 53 0.7× 10 319
C. Wedelin Sweden 11 309 1.7× 161 1.1× 100 1.3× 66 0.8× 127 1.7× 16 416
V. Romagosa Spain 14 334 1.9× 175 1.2× 99 1.2× 84 1.1× 64 0.9× 25 552
Anne Y. Matsushima United States 10 224 1.3× 234 1.5× 41 0.5× 247 3.1× 96 1.3× 13 640
Abraham Avigdor Israel 10 168 0.9× 133 0.9× 52 0.7× 69 0.9× 76 1.0× 14 426
Athina Androulaki Greece 12 145 0.8× 148 1.0× 45 0.6× 31 0.4× 67 0.9× 29 363
Guido Gini Italy 12 241 1.4× 210 1.4× 94 1.2× 104 1.3× 93 1.3× 37 629
Manuel F. Rosado United States 10 333 1.9× 249 1.6× 63 0.8× 87 1.1× 97 1.3× 14 491
Öner Doğan Türkiye 11 127 0.7× 128 0.8× 51 0.6× 33 0.4× 53 0.7× 56 404

Countries citing papers authored by M. Dorreen

Since Specialization
Citations

This map shows the geographic impact of M. Dorreen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dorreen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dorreen more than expected).

Fields of papers citing papers by M. Dorreen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Dorreen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dorreen. The network helps show where M. Dorreen may publish in the future.

Co-authorship network of co-authors of M. Dorreen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Dorreen. A scholar is included among the top collaborators of M. Dorreen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dorreen. M. Dorreen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsvetkova, Elena, Nathalie Aucoin, James Biagi, et al.. (2015). Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. Current Oncology. 22(4). 305–315. 1 indexed citations
2.
3.
Younis, T., et al.. (2013). Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Nab-Paclitaxel Therapy. Current Oncology. 20(5). 484–487. 20 indexed citations
4.
Rayson, Daniel, et al.. (2012). Incidence of Febrile Neutropenia during Adjuvant Chemotherapy for Breast Cancer: A Prospective Study. Current Oncology. 19(3). 216–218. 8 indexed citations
5.
6.
Winquist, Eric, et al.. (2004). A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.. PubMed. 11(6). 2445–9. 4 indexed citations
7.
Glück, Stefan, Colin Germond, Pedro López, et al.. (1998). A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer. European Journal of Cancer. 34(7). 1008–1014. 19 indexed citations
8.
Glück, Stefan, et al.. (1997). High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach. Bone Marrow Transplantation. 20(6). 431–434. 35 indexed citations
9.
Dorreen, M.. (1993). The gestational trophoblastic diseases: A review of their presentation and management. Clinical Oncology. 5(1). 46–56. 6 indexed citations
10.
McIntyre, Catherine, Karen Chapman, M. Dorreen, et al.. (1992). Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants. European Journal of Cancer. 28(1). 58–63. 27 indexed citations
11.
Oza, Amit M., TS Ganesan, M. Dorreen, et al.. (1992). Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years. British Journal of Cancer. 65(3). 429–437. 8 indexed citations
12.
Dorreen, M., et al.. (1992). Stage I seminoma of the testis: Is post-orchidectomy surveillance a safe alternative to routine postoperative radiotherapy?. Clinical Oncology. 4(5). 284–286. 35 indexed citations
13.
Hayat, Khizar, Lesley J. Bruce, Robert C. Rees, et al.. (1991). Malignant melanoma and renal cell carcinoma: Immunological and haematological effects of recombinant human interleukin-2. European Journal of Cancer and Clinical Oncology. 27(8). 1009–1014. 18 indexed citations
14.
Dorreen, M., G. W. Pennington, D. R. Millar, A Hill, & F. E. Neal. (1988). Results of Low-Dose Methotrexate Treatment of Persistent Gestational Trophoblastic Disease in Sheffield 1980–1987. Acta Oncologica. 27(5). 551–556. 4 indexed citations
15.
16.
Dorreen, M.. (1987). Second malignancy in lymphoma. Baillière s Clinical Haematology. 1(1). 191–204. 1 indexed citations
17.
Dorreen, M., J A Habeshaw, A G Stansfeld, P. F. M. Wrigley, & Tim Lister. (1984). Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: An immunohistological study. British Journal of Cancer. 49(4). 465–476. 57 indexed citations
18.
Dorreen, M., P. F. M. Wrigley, A. E. Jones, et al.. (1984). The management of localized, infradiaphragmatic Hodgkin's disease: Experience of a rare clinical presentation at St Bartholomew's Hospital. Hematological Oncology. 2(4). 349–357. 24 indexed citations
19.
Dorreen, M., et al.. (1984). Adult Fanconi syndrome progressing to multiple myeloma.. Journal of Clinical Pathology. 37(11). 1256–1258. 6 indexed citations
20.
Lister, Tim, et al.. (1983). The treatment of stage IIIA Hodgkin's disease.. Journal of Clinical Oncology. 1(12). 745–749. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. P. Vassilakopoulos Breakdown of academic impact, for papers by Kong‐Chao Chang Breakdown of academic impact, for papers by C. Wedelin Breakdown of academic impact, for papers by V. Romagosa Breakdown of academic impact, for papers by Anne Y. Matsushima Breakdown of academic impact, for papers by Abraham Avigdor Breakdown of academic impact, for papers by Athina Androulaki Breakdown of academic impact, for papers by Guido Gini Breakdown of academic impact, for papers by Manuel F. Rosado Breakdown of academic impact, for papers by Öner Doğan
Rankless by CCL
2026